Truist Financial Corp Sells 35,520 Shares of Teradyne, Inc. $TER

Truist Financial Corp trimmed its position in Teradyne, Inc. (NASDAQ:TERFree Report) by 79.7% during the second quarter, according to its most recent 13F filing with the SEC. The fund owned 9,068 shares of the company’s stock after selling 35,520 shares during the period. Truist Financial Corp’s holdings in Teradyne were worth $815,000 as of its most recent filing with the SEC.

Other hedge funds have also recently bought and sold shares of the company. Berbice Capital Management LLC boosted its stake in Teradyne by 200.0% in the first quarter. Berbice Capital Management LLC now owns 300 shares of the company’s stock valued at $25,000 after acquiring an additional 200 shares during the last quarter. Manchester Capital Management LLC boosted its stake in Teradyne by 44.7% in the first quarter. Manchester Capital Management LLC now owns 453 shares of the company’s stock valued at $37,000 after acquiring an additional 140 shares during the last quarter. Brooklyn Investment Group boosted its stake in Teradyne by 189.9% in the first quarter. Brooklyn Investment Group now owns 461 shares of the company’s stock valued at $38,000 after acquiring an additional 302 shares during the last quarter. Steph & Co. bought a new position in Teradyne in the second quarter valued at approximately $43,000. Finally, Summit Securities Group LLC bought a new position in Teradyne in the first quarter valued at approximately $58,000. 99.77% of the stock is currently owned by institutional investors.

Insider Activity at Teradyne

In related news, CEO Gregory Stephen Smith sold 554 shares of the firm’s stock in a transaction on Monday, September 22nd. The shares were sold at an average price of $126.39, for a total transaction of $70,020.06. Following the sale, the chief executive officer directly owned 95,885 shares in the company, valued at $12,118,905.15. This trade represents a 0.57% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Insiders have sold 2,216 shares of company stock worth $251,028 in the last quarter. Company insiders own 0.16% of the company’s stock.

Teradyne Trading Up 5.3%

Shares of Teradyne stock opened at $139.13 on Tuesday. The company has a market capitalization of $22.13 billion, a PE ratio of 48.14, a PEG ratio of 2.78 and a beta of 1.82. Teradyne, Inc. has a 12 month low of $65.77 and a 12 month high of $150.71. The stock’s fifty day simple moving average is $122.07 and its 200 day simple moving average is $97.21.

Teradyne (NASDAQ:TERGet Free Report) last issued its quarterly earnings data on Tuesday, July 29th. The company reported $0.57 EPS for the quarter, topping analysts’ consensus estimates of $0.54 by $0.03. Teradyne had a net margin of 16.59% and a return on equity of 18.16%. The business had revenue of $651.80 million for the quarter, compared to analyst estimates of $649.02 million. During the same period last year, the business posted $0.86 earnings per share. The firm’s quarterly revenue was down 10.7% on a year-over-year basis. Teradyne has set its Q3 2025 guidance at 0.690-0.870 EPS. Analysts predict that Teradyne, Inc. will post 3.88 EPS for the current fiscal year.

Teradyne Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, September 29th. Investors of record on Friday, September 5th were issued a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a dividend yield of 0.3%. The ex-dividend date was Friday, September 5th. Teradyne’s dividend payout ratio (DPR) is presently 16.61%.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on TER. Morgan Stanley raised shares of Teradyne from an “underweight” rating to an “equal weight” rating and raised their price objective for the company from $74.00 to $100.00 in a research note on Thursday, July 31st. Cowen reaffirmed a “buy” rating on shares of Teradyne in a research note on Wednesday, July 30th. UBS Group reaffirmed a “buy” rating and issued a $130.00 price objective (up from $120.00) on shares of Teradyne in a research note on Thursday, July 31st. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Teradyne in a research note on Wednesday, October 8th. Finally, JPMorgan Chase & Co. reiterated a “neutral” rating and issued a $102.00 target price (up from $88.00) on shares of Teradyne in a report on Thursday, July 17th. One equities research analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating, six have given a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat.com, Teradyne presently has a consensus rating of “Moderate Buy” and a consensus target price of $122.53.

Read Our Latest Stock Analysis on Teradyne

Teradyne Company Profile

(Free Report)

Teradyne, Inc designs, develops, manufactures, and sells automated test systems and robotics products worldwide. It operates through four segments; Semiconductor Test, System Test, Robotics, and Wireless Test. The Semiconductor Test segment offers products and services for wafer level and device package testing of semiconductor devices in automotive, industrial, communications, consumer, smartphones, cloud, computer and electronic game, and other applications.

Featured Stories

Institutional Ownership by Quarter for Teradyne (NASDAQ:TER)

Receive News & Ratings for Teradyne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teradyne and related companies with MarketBeat.com's FREE daily email newsletter.